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Lumbar puncture (LP) is a critical part of the diagnostic algorithm to measure 
opening pressure and contents in all those presenting with raised intracranial 
pressure (ICP).[1-4] The diagnosis of IIH is one of exclusion, and at the point of initial 
presentation, there is no clinically recognised sign that can diagnose IIH above other 
causes of raised ICP.[1-4] Gates et al. [5] raise an interesting discussion regarding 
the utility of needle tip type for the lumbar puncture (LP) procedure in those who are 
diagnosed subsequently with idiopathic intracranial hypertension (IIH).[5]  Whilst the 
first guidelines in IIH [1] and the European IIH guidelines [2] have recommended that 
therapeutic serial LPs are not advocated as a long-term treatment strategy for IIH 
due to the lack of high-quality peer reviewed evidence [1,2], to which the authors 
agree, we accept that there are centres that continue this practice.  
 
There are established complications of LPs which include local discomfort, low 
pressure headaches and more rarely infection or local haemorrhage.[6] Although LP 
induces a transient reduction of CSF pressure the effect is typically short lived with 
pressures found to rise rapidly after the procedure, despite the amount of CSF 
drained.[7] Therapeutic LP has limited application for managing headache, as 
headache improves in 71%, but the improvement is small (1 point on the verbal 
rating score 0-10) and there is also a 64% chance of a significant headache 
exacerbation in the week following LP in IIH patients.[8] More importantly, those with 
IIH frequently report high pain scores and a very negative emotional experience 
when they undergo a LP.[9]. IIH is associated with poor quality of life and the impact 
of LP needle type utilised (atraumatic versus cutting needle) have not been 
evaluated to consider the long term pros and cons for the patient.[10] 
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As the incidence of IIH has been documented to rise, with an unexpected increase in 
unsolicited hospital admissions [11], it is important that the natural history of the 
condition is considered, as relapse is common, even in those who appear to initially 
have a rapid improvement post LP. [12] Expert clinical experience, as cited by Gates 
et al.[5], provides important insights to inform hypothesis driven research.  
 
Within the United Kingdom the authors have occasionally seen the phenomenon of 
IIH resolution post LP, we have tended to observe that these patients seen may be 
on a mild spectrum of the disease. We have not seen patients with moderate to 
severe IIH go into prolonged remission immediately following an LP. So, before the 
call for a change to clinical practice without clear evidence [5], more robust research 
is needed to evaluate the extent of resolution of IIH post LP, the role of needle type, 
the baseline disease severity in these patients, and the duration of the remission 
following LP. Our experience of following patient’s long term, is that the disease can 
fluctuate and in those that settle following an LP, without further intervention, they 
typically re-present with recurrent disease further down the line. With the emergence 
of telemetric ICP monitoring in IIH we are gaining fascinating insight into the 
relationship between ICP and clinical signs and the dramatic changes in ICP seen 
over the course of progressing disease. We have noted that ICP varies widely in IIH 
with progression from diagnosis, to fulminant disease with declining vision, until ICP 
was temporarily controlled with lumbar drainage (which did not reverse the disease 
process) and ultimately the ICP settled following a definitive CSF shunt [12]. The 
lumbar puncture needle choice may be the tip of the iceberg in managing and 
understanding raised ICP in IIH. 
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